0001246360-15-002806.txt : 20150805 0001246360-15-002806.hdr.sgml : 20150805 20150805162132 ACCESSION NUMBER: 0001246360-15-002806 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150803 FILED AS OF DATE: 20150805 DATE AS OF CHANGE: 20150805 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 0424 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Martha Geoffrey CENTRAL INDEX KEY: 0001560409 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 151029256 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWAY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 4 1 form.xml PRIMARY DOCUMENT X0306 4 2015-08-03 false 0001613103 Medtronic plc MDT 0001560409 Martha Geoffrey 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 false true false false EVP & GroupPres Restora Therap Ordinary Shares 2015-08-03 4 A false 9830 0 A 29701 D Employee Stock Option (right to buy) 78 2015-08-03 4 A false 39317 0 A 2016-08-03 2025-08-03 Ordinary Shares 39317 39317 D Employee Stock Option (right to buy) 78 2015-08-03 4 A false 1283 0 A 2016-08-03 2025-08-03 Ordinary Shares 1283 40600 D The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2018 equals or exceeds a 3% compound annual growth rate, as determined by the Compensation Committee. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Rhonda L. Ingalsbe, Attorney-in-fact 2015-08-05